Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

Accumulating evidence demonstrates the decisive role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade in preclinical tumor models, as well as in cancer patients. In synthesis, it appears that a normal int...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Daillère, Romain, Derosa, Lisa, Bonvalet, Mélodie, Segata, Nicola, Routy, Bertrand, Gariboldi, Manuela, Budinská, Eva, De Vries, I. Jolanda M., Naccarati, Alessio Gordon, Zitvogel, Valérie, Caldas, Carlos, Engstrand, Lars, Loilbl, Sibylle, Fieschi, Jacques, Heinzerling, Lucie, Kroemer, Guido, Zitvogel, Laurence
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7466862/
https://ncbi.nlm.nih.gov/pubmed/32934879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1774298
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados